Atlas Trials

SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan

Clinical trial NCT05057806 · RECRUITING

Trial details

NCT number
NCT05057806
Sponsor
The University of Texas Health Science Center at San Antonio
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Type2 DiabetesHeart Failure With Preserved Ejection Fraction
Start date
2021-01-13
Primary completion
2026-11-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.